Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment ...

"It's important that we hear from people, because it shapes the future as far as what is discussed within the Pentagon and on ...

These findings align closely with external research as well. For example, Foundry's 2023 ABM and Intent Benchmarking Study ...

In art, brush marks can be seen as a flaw or the signature of a noted painter. Similarly, what appears to be operational ...

Humans also create value through ethical restraint, the ability to recognize when not to cut corners, when to delay, and when to prioritize patient safety or scientific rigor over speed. That human ...

This article is sponsored by ECP. In this Voices interview, Senior Housing News connects with Carly Smith, Vice President of Product at ECP, to explore ...

President Donald Trump signed an executive order on Dec. 11, 2025, that aims to supersede state-level artificial intelligence ...

A year after the SEC sent 14 of its 16 teams to the NCAA Tournament, the Big 12 appears to be the power conference to watch ...

In the race against the "Carbon Cliff", AI is becoming an essential tool for balancing the economic equation. AI integration ...

A new study published today in Science Translational Medicine by researchers at The University of Texas MD Anderson Cancer Center details a therapeutic vulnerability in  patients with an aggressive ...

Python''s popularity is surging. In 2025, it achieved a record 26.14% TIOBE index rating, the highest any language has ever ...